Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Posted Basic Consolidated EPS Of $-0.3586

0

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) annual basic consolidated EPS was $-0.3586 for the period ended 2014-12-31. The basic consolidated EPS was $-0.3586 for the quarter ended 2014-12-31.

EPS from continuing operations

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)’s basic EPS from continuing operations was $-0.3586 for the fiscal year 2014-12-31. For the quarter ended 2014-12-31 it stood at $-0.3586

EPS contribution from parent

From the parent company Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) posted basic EPS of $-0.3586 for the fiscal ended 2014-12-31. For the quarter that ended on 2014-12-31 the figure stood at $-0.3586.

Basic net EPS

The Basic net EPS of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) was $-0.36 for the period ended 2014-12-31. The figure stood at $-0.36 for the quarter that ended 2014-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2014-12-31 stood at $-0.3586. While the figure for the quarter ended 2014-12-31 stood at $-0.3586.

Basic diluted EPS

The diluted EPS from continuing operation of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) stood at $-0.3586 for the fiscal 2014-12-31. The figure for the quarter ended 2014-12-31 stood at $-0.3586

Net diluted EPS

The Net diluted EPS was $-0.36 for the fiscal 2014-12-31. The figure for the quarter ended 2014-12-31 stood at $-0.36.

Diluted EPS from parent

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) diluted EPS from the parent company for the fiscal 2014-12-31 was $-0.3586. The figure for the quarter ended 2014-12-31 was $-0.3586

The net basic EPS was $-2.62 for fiscal 2014-12-31. The figure for the quarter ended 2014-12-31 was $-2.62.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 11 times, 1 visits today)